Practical Challenges and Opportunities: Implementing Evidence-Based Management of HFmrEF/HFpEF - The 2022 AHA/ACC/HFSA Guidelines and Beyond

While evidence-based therapies continue to expand, substantial implementation gap exists for the real-world application of the treatment guidelines for HFmrEF/HFpEF especially when navigating comorbidities and other treatment barriers. This episode explores how clinicians can translate the guidelines into practical everyday care for patients.